Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
PrECOG, LLC.
Fundación GECP
University Medical Center Groningen
CHA University
City of Hope Medical Center
Peking University Cancer Hospital & Institute
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sun Yat-sen University
Azienda Policlinico Umberto I
Aetion, Inc.
Aetion, Inc.
Swami Rama Himalayan University
University Medical Center Groningen
Shanghai Zhongshan Hospital
Peking University Third Hospital
Ain Shams University
University of California, San Diego
Sun Yat-sen University
Holy Name Medical Center, Inc.
European Lung Cancer Working Party
Sun Yat-sen University
Sungkyunkwan University
Xijing Hospital
University of Pisa
Wake Forest University Health Sciences
Ziekenhuis Oost-Limburg
First People's Hospital of Foshan
Roswell Park Cancer Institute
Royal Marsden NHS Foundation Trust